Braftovi Interactions
There are 628 drugs known to interact with Braftovi (encorafenib), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 278 are major, 339 are moderate, and 11 are minor.
- View all 628 medications that may interact with Braftovi
- View Braftovi alcohol/food interactions (1)
- View Braftovi disease interactions (5)
Most frequently checked interactions
View interaction reports for Braftovi (encorafenib) and the medicines listed below.
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adriamycin (doxorubicin)
- Advate (antihemophilic factor)
- Aldurazyme (laronidase)
- Amicar (aminocaproic acid)
- amoxicillin
- Aubagio (teriflunomide)
- Austedo (deutetrabenazine)
- biotin
- Blincyto (blinatumomab)
- Brineura (cerliponase alfa)
- Caprelsa (vandetanib)
- Cerdelga (eliglustat)
- famotidine
- Imbruvica (ibrutinib)
- levothyroxine
- lisinopril
- Mektovi (binimetinib)
- melatonin
- Pomalyst (pomalidomide)
- Pradaxa (dabigatran)
- Prolia (denosumab)
- Rexulti (brexpiprazole)
- Soliris (eculizumab)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Tarceva (erlotinib)
- Tecfidera (dimethyl fumarate)
- Valium (diazepam)
- Vitamin D3 (cholecalciferol)
Braftovi alcohol/food interactions
There is 1 alcohol/food interaction with Braftovi (encorafenib).
Braftovi disease interactions
There are 5 disease interactions with Braftovi (encorafenib) which include:
Report options
More about Braftovi (encorafenib)
- Braftovi consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Betaseron
Betaseron is used to treat relapsing multiple sclerosis (MS). Learn about side effects ...
Extavia
Extavia is used to treat the relapsing forms of multiple sclerosis. Learn about side effects ...
Leucovorin
Leucovorin is used for anemia, megaloblastic, colorectal cancer, folic acid antagonist overdose ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
